RheumNow's expanded coverage of the #ACR2019 annual meeting is sponsored in part by Sanofi Genzyme and Regeneron. All content chosen by RheumNow and its faculty.

Small study suggests subclinical inflammation detected by MRI in joints of hand in PsA patients in MDA. Abst #1171 #ACR19 #ACRbest @RheumNow https://t.co/WM3kmG1lYQ https://t.co/FaatgdlYbw

• Evidence of Subclinical Joint Inflammation of Hands by Magnetic Resonance Imagi…

How often do US gout patients have #urate testing? The % of the year they have a ULT script? The answers may surprise you...not in a good way. Dr Larry Edwards reviews his presentation at #ACR2019 on health care pathway/treatment for over 1 million #gout patients. @RheumNow https://t.co/Vg1axeEEu4

Toxicity of JAK inhibitors #ACR19 @RheumNow https://t.co/rqy1IfSEyP

NEW Guidelines for the Management of GCA from #ACR19 in one table 1. Recommend TAB over TA U/S for dx GCA 2. Pts should receive TCZ upfront 3. Don't treat asymptomatic CRP, monitor patients closely Overall in line with my practice, though I'm pro TA U/S @RheumNow https://t.co/4mxcqqi1bA

IL-1 blockade beneficial in MAS. Ferritin to ESR ratio useful for identifying these patients. Cytokines Storm Syndrome is one way of thinking of the spectrum of conditions like MAS, HLH, auto inflammatory disease which respond to IL-1 and IL-6 blockade. Cron R #ACR19 @RheumNow

Newer JAK inhibitors in development #ACR19 @RheumNow https://t.co/sRIHv7PUyT

Numerous FOAMed (free open access medical education) options for rheumatology: - @RheumNow - @HealioRheum - @HRheuminations - @EBRheum - @RheumJC - @AWIRGROUP #ACR19 https://t.co/cnoEWXfozZ

Virtually every parent of a child with a rheumatic disease uses Facebook to learn about other children with similar health conditions.  #ACR19 @rheumnow #Abstr 1756 #ACRBest https://t.co/3L2fQ9vS8X

• Health­-related Social Media Use by Parents of Children with Rheumatic Diseases…

#ACR19 Rheumatology Social Media and the medical professional — @BolekBerqui Thread ⬇️⬇️⬇️ @RheumNow

RheumNow's expanded coverage of the #ACR2019 annual meeting is sponsored in part by Novartis. All content chosen by RheumNow and its faculty.

So much JAKi right now - RA, PsA, SLE, and more! Last tweet of the day. Curious to hear... Which JAKi do you think will win the JAK-wars? @RheumNow